Monopar Therapeutics Cash from Financing (TTM) Analysis

Monopar Therapeutics Inc (MNPR)

0.7552 +0.10 (+14.42%) USD | NASDAQ | May 03, 16:00

0.7272 -0.03 (-3.71%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	2.027M
September 30, 2023	1.831M
June 30, 2023	1.561M
March 31, 2023	0.8543M
December 31, 2022	0.0329M
September 30, 2022	-0.1136M
June 30, 2022	-0.0999M
March 31, 2022	-0.0584M
December 31, 2021	10.88M
September 30, 2021	10.88M
June 30, 2021	17.62M
March 31, 2021	18.60M
December 31, 2020	8.182M

Date	Value
September 30, 2020	17.58M
June 30, 2020	10.83M
March 31, 2020	9.869M
December 31, 2019	9.347M
September 30, 2019	-0.2457M
June 30, 2019	-0.2324M
March 31, 2019	-0.2201M
December 31, 2018	-0.2063M
September 30, 2018	0.01M
June 30, 2018	7.511M
March 31, 2018	8.546M
December 31, 2017	9.536M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.2457M

Minimum

Sep 2019

18.60M

Maximum

Mar 2021

6.281M

Average

2.027M

Median

Dec 2023

Cash from Financing (TTM) Benchmarks